BACH1 ve Hemoglobin E/Beta-Talasemi Globin Sunumu Korelasyonu

Conclusion: This study indicates that the expression of BACH1 could be elevated as a compensatory mechanism to decrease the globin chain imbalance as well as to reduce the oxidative stress found in HbE/?-thalassemia.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: The diverse clinical phenotype of hemoglobin E (HbE)/?thalassemia has not only confounded clinicians in matters of patient management but has also led scientists to investigate the complex mechanisms involved in maintaining the delicate red cell environment where, even with apparent similarities of ?- and ?-globin genotypes, the phenotype tells a different story.

📊

Key Findings & Data:The BTB and CNC homology 1 (BACH1) protein is known to regulate ?- and ?-globin gene transcriptions during the terminal differentiation of erythroid cells.

💡

Conclusion & Impact:Conclusion: This study indicates that the expression of BACH1 could be elevated as a compensatory mechanism to decrease the globin chain imbalance as well as to reduce the oxidative stress found in HbE/?-thalassemia.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Objective: The diverse clinical phenotype of hemoglobin E (HbE)/?thalassemia has not only confounded clinicians in matters of patient management but has also led scientists to investigate the complex mechanisms involved in maintaining the delicate red cell environment where, even with apparent similarities of ?- and ?-globin genotypes, the phenotype tells a different story. The BTB and CNC homology 1 (BACH1) protein is known to regulate ?- and ?-globin gene transcriptions during the terminal differentiation of erythroid cells. With the mutations involved in HbE/?-thalassemia disorder, we studied the role of BACH1 in compensating for the globin chain imbalance, albeit for fine-tuning purposes. Materials and Methods: A total of 47 HbE/?-thalassemia samples were analyzed using real-time quantitative polymerase chain reaction and correlated with age, sex, red blood cell parameters, globin gene expressions, and some clinical data.Results: The BACH1 expression among the ?-thalassemia intermedia patients varied by up to 2-log differences and was positively correlated to age; ?-, ?-, and ?-globin gene expression level; and heme oxygenase 1 protein. BACH1 was also negatively correlated to reticulocyte level and had a significant correlation with splenectomy. Conclusion: This study indicates that the expression of BACH1 could be elevated as a compensatory mechanism to decrease the globin chain imbalance as well as to reduce the oxidative stress found in HbE/?-thalassemia.

Özet

Amaç: Hemoglobin E (HbE)/?-talaseminin çeşitli klinik fenotipleri klinisyenlerin hasta yönetimi esnasında zihinlerini karıştırmakla kalmamış, ?- ve ?-globin genotiplerinde bariz benzerlikler varken fenotiplerde farklılıklar bulunduğundan bilim insanlarının hassas eritrosit çevrenin muhafaza edilmesinde yer alan karmaşık mekanizmaları incelemelerine de ön ayak olmuştur. BTB ve CNC homoloji 1 (BACH1) proteininin eritroid hücrelerin son farklılaşması sırasında ?- and ?-globin gen transkripsiyonlarını ayarladığı bilinmektedir. HbE/?-talasemi hastalığındaki mutasyonlar ile her ne kadar ince ayar amaçlı ise de BACH1'in globin zincir dengesizliğini kompanse etmedeki rolünü inceledik. Gereç ve Yöntemler: Toplam 47 HbE/?-talasemi örneği gerçek zamanlı kantitatif polimeraz zincir reaksiyonu ile incelendi ve yaş, cinsiyet, eritrosit değişkenleri, globin gen sunumları ve bazı klinik veriler ile korele edildi. Bulgular: ?-talasemi intermedia hastalarındaki BACH1 sunumu 2-log'a kadar farklılık göstermekteydi ve yaş; ?-, ?- ve ?-globin gen sunum düzeyleri; ve hem oksijenaz 1 proteini ile pozitif korelasyonu vardı. Ayrıca BACH1'in retikülosit düzeyi ile negatif korelasyonu vardı ve splenektomi ile anlamlı korelasyonu bulunmaktaydı. Sonuç: Bu çalışma hem HbE/?-talasemide bulunan oksidatif stresi hem de globin zincir dengesizliğini azaltmak için BACH1 sunumunun kompansasyon mekanizması olarak artabileceğini göstermiştir.

🔖

Cite This Article

LEE, T. Y., MUNİANDY, L., TEH, L. K., ABDULLAH, M., GEORGE, E., SATHAR, J., LAİ, M. I. (2016). BACH1 ve Hemoglobin E/Beta-Talasemi Globin Sunumu Korelasyonu. Turkish Journal of Hematology, Cilt: 33 - Sayı: 1, 15–20. https://ajindex.com/articles/413099

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (9)

Fucharoen S, Weatherall DJ. The hemoglobin E thalassemias. Cold Spring Harb Perspect Med 2012;2:a011734. Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ. Studies in hemoglobin E beta-thalassaemia. Br J Haematol 2008;141:388-397. Thein SL. Genetic insights into the clinical diversity of ?-thalassaemia. Br J Haematol 2004;124:264-274.
Igarashi K, Hoshino H, Muto A, Suwabe N, Nishikawa S, Nakauchi H, Yamamoto M. Multivalent DNA binding complex generated by small Maf and BACH1 as a possible biochemical basis for ?-globin locus control region complex. J Biol Chem 1998;273:11783-11790.
Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, Igarashi K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 2002;19:5216-5224.
Tahara T, Sun J, Igarashi K, Taketani S. Heme-dependent up-regulation of the ?-globin gene expression by transcriptional repressor BACH1 in erythroid cells. Biochem Biophys Res Commun 2004;324:77-85.
Tahara T, Sun J, Nakanishi K, Yamamoto M, Mori H, Saito T, Fujita H, Igarashi K, Taketani S. Heme positively regulates the expression of beta-globin at the locus control region via the transcriptional factor BACH1 in erythroid cells. J Biol Chem 2004;279:5480-5487.
De Franceschi L, Bertoldi M, De Falco L, Santos Franco S, Ronzoni L, Turrini F, Colancecco A, Camaschella C, Cappellini MD, Iolascon A. Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in ?-thalassemic erythropoiesis. Haematologica 2011;96:1595-1604. Old JM. Hematological applications: hemoglobinopathies. Methods Mol Med 2004;92:203-219.
Wong YC, George E, Tan KL, Yap SF, Chan LL, Tan JA. Molecular characterisation and frequency of G? Xmn I polymorphism in Chinese and Malay beta-thalassaemia patients in Malaysia. Malays J Pathol 2006;28:17- 21. Lai MI, Jiang J, Silver N, Best S, Menzel S, Mijovic A, Colella S, Ragoussis J, Garner C, Weiss MJ, Thein SL. Alpha-hemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. Br J Haematol 2006;133:675-682.
Watanapokasin Y, Winichagoon P, Fuchareon S, Wilairat P. Relative quantitation of mRNA in beta-thalassemia/Hb E using real-time polymerase chain reaction. Hemoglobin 2000;24:105-116.
Igarashi K, Sun J. The heme-BACH1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid